Concepedia

Judy Schnyder

JS

Statistics

Publications

3

Citations

137

H-Index

3

Active since

2011

Affiliations

Gem Pharmaceuticals (United States)(Current)

Mayo Clinic in Arizona

Campbell Clinic

Clearview Cancer Institute

Judy Schnyder is an author at Gem Pharmaceuticals (United States) specializing in cancer therapeutics, lung cancer, and oncology.

Top concepts

Publications per year

2011–2014

3

Publications

3

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer

Corey J. Langer, István Albert, Helen J. Ross et al. · Lung Cancer · 2014 · 69 citations

, , +8

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

Alberto Chiappori, Marshall T. Schreeder, M. Moezi et al. · British Journal of Cancer · 2012 · 49 citations · Full text

, , +15

A randomized phase II study of carboplatin (C) and etoposide (E) with or without pan-BCL-2 antagonist obatoclax (Ob) in extensive-stage small cell lung cancer (ES-SCLC).

Corey J. Langer, István Albert, P Kovács et al. · Journal of Clinical Oncology · 2011 · 19 citations

, , +20

1–3 of 3